Stock HLF HERBALIFE LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Herbalife Ltd.

Equities

HLF

KYG4412G1010

Food Processing

Market Closed - Nyse
Other stock markets
 21:00:02 26/04/2024 BST 		5-day change 1st Jan Change
8.81 USD -0.79% Intraday chart for Herbalife Ltd. -0.34% -42.27%
04-12 Herbalife Completes $1.6 Billion Secured Refinancing to Strengthen Balance Sheet DJ
04-12 Herbalife Ltd. Completes $1.6 Billion Senior Secured Refinancing, Includes $1.2 Billion Senior Secured Debt and $400 Million Revolver CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 6,545 5,838 4,180 1,457 1,512 879.1 -
Enterprise Value (EV) 1 6,545 5,838 6,341 1,457 1,512 879.1 879.1
P/E ratio 21.7 x 17.3 x 9.91 x 4.61 x 10.7 x 5.14 x 3.3 x
Yield - - - - - - -
Capitalization / Revenue 1.34 x 1.05 x 0.72 x 0.28 x 0.3 x 0.17 x 0.16 x
EV / Revenue 1.34 x 1.05 x 0.72 x 0.28 x 0.3 x 0.17 x 0.16 x
EV / EBITDA 9.05 x 6.71 x 4.79 x 2.1 x 2.65 x 1.63 x 1.39 x
EV / FCF - - 13.5 x 7.43 x 6.8 x 6.53 x 3.95 x
FCF Yield - - 7.39% 13.5% 14.7% 15.3% 25.3%
Price to Book - - -3.19 x -1.15 x -1.44 x -0.94 x -1.2 x
Nbr of stocks (in thousands) 137,293 121,500 102,133 97,883 99,112 99,787 -
Reference price 2 47.67 48.05 40.93 14.88 15.26 8.810 8.810
Announcement Date 18/02/20 17/02/21 23/02/22 14/02/23 14/02/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 4,877 5,542 5,803 5,204 5,062 5,125 5,357
EBITDA 1 722.8 870.3 873.5 694.5 570.6 540.6 633.8
EBIT 1 625.1 770 765.9 579.1 457.3 413.9 502.5
Operating Margin 12.82% 13.89% 13.2% 11.13% 9.03% 8.08% 9.38%
Earnings before Tax (EBT) 1 451.4 516.4 560.8 424.8 203 189 335.2
Net income 1 311 372.6 447.2 321.3 142.2 171.6 263.2
Net margin 6.38% 6.72% 7.71% 6.17% 2.81% 3.35% 4.91%
EPS 2 2.200 2.770 4.130 3.230 1.420 1.715 2.668
Free Cash Flow 1 - - 308.9 196.1 222.5 134.6 222.8
FCF margin - - 5.32% 3.77% 4.4% 2.63% 4.16%
FCF Conversion (EBITDA) - - 35.36% 28.24% 38.99% 24.89% 35.15%
FCF Conversion (Net income) - - 69.07% 61.03% 156.47% 78.4% 84.67%
Dividend per Share 2 - - - - - - -
Announcement Date 18/02/20 17/02/21 23/02/22 14/02/23 14/02/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,431 1,318 1,336 1,393 1,295 1,181 1,252 1,314 1,281 1,215 1,265 1,332 1,297 1,237 1,312
EBITDA 1 222.4 131.6 185.6 195.4 182.8 130.7 128.9 169.6 163.3 108.8 119 158.2 152.2 110.9 145
EBIT 1 195.8 104.1 156.4 166 154.2 102.5 101.3 140.5 134.9 80.6 88.23 126 120.4 79.29 112.7
Operating Margin 13.68% 7.9% 11.71% 11.92% 11.91% 8.68% 8.09% 10.69% 10.53% 6.63% 6.97% 9.45% 9.28% 6.41% 8.59%
Earnings before Tax (EBT) 1 151.7 47.6 123.4 124.1 112.9 64.4 31.1 85 69.2 17.7 41 70 63 15 75
Net income 1 117.4 38.2 98.2 86.5 82.2 54.4 29.3 59.9 42.8 10.2 35.59 62.38 51.96 21.68 55.65
Net margin 8.2% 2.9% 7.35% 6.21% 6.35% 4.61% 2.34% 4.56% 3.34% 0.84% 2.81% 4.68% 4.01% 1.75% 4.24%
EPS 2 1.090 0.3700 0.9600 0.8800 0.8300 0.5500 0.2900 0.6000 0.4300 0.1000 0.3525 0.6250 0.5200 0.2175 0.5550
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 02/11/21 23/02/22 03/05/22 02/08/22 31/10/22 14/02/23 02/05/23 02/08/23 01/11/23 14/02/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - 2,161 - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - 2.474 x - - - -
Free Cash Flow 1 - - 309 196 223 135 223
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - 17.6% - - - -
Assets 1 - - 2,545 - - - -
Book Value Per Share 2 - - -12.80 -12.90 -10.60 -9.400 -7.370
Cash Flow per Share 2 - - - 3.540 3.570 3.050 4.550
Capex 1 106 112 151 156 135 158 146
Capex / Sales 2.18% 2.02% 2.61% 3.01% 2.67% 3.07% 2.73%
Announcement Date 18/02/20 17/02/21 23/02/22 14/02/23 14/02/24 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Herbalife Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
8.81 USD
Average target price
11.9 USD
Spread / Average Target
+35.07%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
HERBALIFE LTD. Stock Herbalife Ltd.
-42.27% 879M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+8.20% 7.78B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+0.34% 7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+10.20% 6.52B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-8.10% 3.67B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-14.57% 1.17B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+8.34% 934M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-18.90% 836M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-16.45% 802M
GRAPE KING BIO LTD Stock Grape King Bio Ltd
+0.32% 711M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. HLF Stock
  4. Financials Herbalife Ltd.